A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma - BeOne

A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma

BeOne Study ID

BGB-3111-1002

ClinicalTrials.gov ID

NCT03189524

China Drug Trials ID

CTR20160204

Study Overview

Sex: All

Age: 18 Years / 75 Years

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / 75 Years

Study Documents

Study Protocol Statistical Analysis Plan